DE602004028631D1 - CD20 BINDING POLYPEPTIDE COMPOSITIONS - Google Patents

CD20 BINDING POLYPEPTIDE COMPOSITIONS

Info

Publication number
DE602004028631D1
DE602004028631D1 DE602004028631T DE602004028631T DE602004028631D1 DE 602004028631 D1 DE602004028631 D1 DE 602004028631D1 DE 602004028631 T DE602004028631 T DE 602004028631T DE 602004028631 T DE602004028631 T DE 602004028631T DE 602004028631 D1 DE602004028631 D1 DE 602004028631D1
Authority
DE
Germany
Prior art keywords
binding polypeptide
polypeptide compositions
compositions
binding
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004028631T
Other languages
German (de)
Inventor
Francis J Carr
Stephen Williams
Stephen D Gillies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority claimed from PCT/EP2004/009033 external-priority patent/WO2005016969A2/en
Publication of DE602004028631D1 publication Critical patent/DE602004028631D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE602004028631T 2003-08-14 2004-08-16 CD20 BINDING POLYPEPTIDE COMPOSITIONS Active DE602004028631D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018480 2003-08-14
US52017103P 2003-11-14 2003-11-14
PCT/EP2004/009033 WO2005016969A2 (en) 2003-08-14 2004-08-16 Cd20-binding polypeptide compositions

Publications (1)

Publication Number Publication Date
DE602004028631D1 true DE602004028631D1 (en) 2010-09-23

Family

ID=34196134

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004028631T Active DE602004028631D1 (en) 2003-08-14 2004-08-16 CD20 BINDING POLYPEPTIDE COMPOSITIONS

Country Status (2)

Country Link
CY (1) CY1110844T1 (en)
DE (1) DE602004028631D1 (en)

Also Published As

Publication number Publication date
CY1110844T1 (en) 2015-06-10

Similar Documents

Publication Publication Date Title
CY2016010I1 (en) COMPOSITIONS COMPRISING POLYPEPTIDES
CY2015019I1 (en) MONODISPERSE PEGYLATED NALOXOL COMPOSITIONS
FR2862654B1 (en) FILMOGENATED AMYLACEE COMPOSITION
ATE517635T1 (en) CD20 BINDING MOLECULES
DE602004032093D1 (en) polishing composition
IL211133A (en) Compositions comprising il-6 antibodies
DK1667939T3 (en) Mineral Composition
DE10393374D2 (en) composition
DE602004007143D1 (en) HARDENABLE PERFLUORELASTOMER COMPOSITIONS
SE0500163L (en) Composition
ATE491774T2 (en) GASOLINE COMPOSITION
IL188671A0 (en) Il-6 binding proteins
DE60310914D1 (en) POWDER COMPOSITION
DK1561472T3 (en) Solid Composition
DK1704213T3 (en) kerosene composition
DE602004004388D1 (en) COMPATIBLE COMPOSITIONS
DK1471124T3 (en) Polishing composition
DE602004002503D1 (en) Digital mixer
SE0302495L (en) Transport composition
DE602004018858D1 (en) emulsion composition
DE602004022063D1 (en) MULTI SLIDE
DK1664096T3 (en) Antimicrobial peptides
DK1664095T3 (en) Antimicrobial polypeptides
DE602004000590D1 (en) resin composition
ATE365529T1 (en) SWEAT-INHIBITING COMPOSITIONS